Logo-jrhs
J Res Health Sci. 2022;22(2): e00552. doi: 10.34172/jrhs.2022.87
PMID: 36511264        PMCID: PMC9818038

Original Article

Evaluation of Survival Rate and Associated Factors in Patients with Cervical Cancer: A Retrospective Cohort Study

Fatemeh-sadat Tabatabaei, Arefeh Saeedian, Amirali Azimi, Kasra Kolahdouzan, Ebrahim Esmati * , Afsaneh Maddah Safaei

Cited by CrossRef: 1

1- Alfareh M, Obeid D, Alhoshan H, Basri R, Alhamlan F. Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey. Intl J Gynecology & Obste. 2024;167(1):154 [Crossref]
2- Wang L, Wang Y, Yang K, Hu X, Ye G. Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer. Biomarkers in Medicine. 2024;18(20):869 [Crossref]
3- Maddah Safaei A, Esmati E, Gomar M, Akhavan S, Sheikh Hasani S, Malekzadeh Moghani M, Zamani N, Moshtaghi M, Malek M, Jafari F, Sharifian A, Kolahdouzan K. Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial. J Cancer Res Clin Oncol. 2024;150(1) [Crossref]
4- Silva A, Sousa K, Santos A, Silva D, Coelho R, Xavier L, Rosa V, Ferreira E, Rocha S, Santos D, Ribeiro K, Furtado G, Nóbrega A. Neoplasia do colo de útero e mortalidade: uma metanálise. Cad Pedagógico. 2024;21(8):e7136 [Crossref]